Welcome to LookChem.com Sign In|Join Free
  • or
4-[4-(1-tert-Butylcarbamoyl-naphthalen-2-yl)-2-oxo-butyl]-1-isopropyl-1,2,5,6-tetrahydro-pyridine-3-carboxylic acid tert-butylamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

158434-94-7

Post Buying Request

158434-94-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

158434-94-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 158434-94-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,4,3 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 158434-94:
(8*1)+(7*5)+(6*8)+(5*4)+(4*3)+(3*4)+(2*9)+(1*4)=157
157 % 10 = 7
So 158434-94-7 is a valid CAS Registry Number.

158434-94-7Upstream product

158434-94-7Downstream Products

158434-94-7Relevant academic research and scientific papers

Structure-based design and synthesis of substituted 2-butanols as nonpeptidic inhibitors of HIV protease: Secondary amide series

Reich, Siegfried H.,Melnick, Michael,Pino, Mark J.,Fuhry, Mary Ann M.,Trippe, Anthony J.,Appelt, Krzysztof,Davies II, Jay F.,Wu, Bor-Wen,Musick, Linda

, p. 2781 - 2794 (1996)

The design, synthesis, and crystallographic analysis of protein- inhibitor complexes is described for a novel series of nonpeptidic HIV protease (HIV Pr) inhibitors. Beginning with a cocrystal structure of a Phe- Pro peptidomimetic bound to the HIV Pr, design was initiated that resulted in the substituted 2-butanol compound 8 as the lead compound (K(i) = 24.5 μM, racemic mixture). Modifications on the initial compound were then made on the basis of its cocrystal structure with HIV Pr and inhibition data, resulting in compounds with enhanced potency against the enzyme (compound 18, K(i) = 0.48 μM). These inhibitors were found to bind to the enzyme essentially as predicted on the basis of the original design hypothesis. Stereospecific synthesis of individual enantiomers confirmed the prediction of a binding preference for the S alcohol stereochemistry. Modest antiviral activity was demonstrated for several of the more potent HIV Pr inhibitors in a HIV-1 infected CEM-SS cell line.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 158434-94-7